FGF21 and coronary artery disorder: Elevated serum FGF21 levels have also been recently reported in subjects with coronary heart disease or carotid artery plaques independently of established cardiovascular risk factors, suggesting its potential role as a biomarker for atherosclerotic diseases (49–51).